Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FS8WC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,965
Award facts
- Contract value 100% obligated
- $12,964.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,964.64 to AmerisourceBergen Drug Corp for the supply of KEVZARA (sarilumab) 200 mg/1.14 mL pen injections. This non-competitive delivery order, issued on January 21, 2026, with completion targeted for January 22, 2026, represents a firm fixed-price purchase under an existing indefinite delivery contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The product will be delivered to the Conshohocken, PA location, with AmerisourceBergen operating as a subsidiary of its parent company Cencora, Inc.
This delivery order is executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. KEVZARA is a specialty biologic medication used in the treatment of rheumatoid arthritis, reflecting the vendor's role in supplying specialized medical commodities across multiple therapeutic domains. The award demonstrates the vendor's capability to fulfill federal pharmaceutical procurement requirements on a competitive basis, as evidenced by its extensive portfolio of delivery orders for both brand-name and generic medications supporting military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FS8WC?
SPE2DR26FS8WC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FS8WC worth?
The government has obligated $12,965 on SPE2DR26FS8WC.
Is contract SPE2DR26FS8WC an order under another contract?
Yes. SPE2DR26FS8WC is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8WC competed?
The extent of competition for SPE2DR26FS8WC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award